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INTRODUCTION
Toxoplasma gondii is a zoonotic pathogen and one of the 
most widespread parasites, and chronically infects approxi-
mately 30% of the global human population, as well as ani-
mal species [1]. T. gondii is the etiological agent of toxoplas-
mosis, causing severe neurological deficits in immunosup-
pressed individuals and causing hydrocephalus, chorioretinitis, 
and blindness in congenitally infected newborns [2]. The 
main effect of T. gondii infection in farm animals is abortion, 
which causes significant reproductive losses, and as a result, 
economic losses [3]. The most frequently used and successful 
chemotherapy of T. gondii infection is a combination of antifo-
lates, such as pyrimethamine and sulfadiazine. However, other 
options are desirable because of the emergence of resistant 
strains and side effects caused by the available anti-parasitic 
agents [4].
Sterculic acid is naturally found in plants such as Sterculia 
foetida, which is used as an anti-parasite drug in traditional 
Chinese medicine. Sterculic acid specifically inhibits the con-
version of stearic acid to oleic acid by Δ9-desaturation [5]. 
Methyl esters of sterculic acid and analogues were shown to 
have parasiticidal activities against the asexual blood stage of 
Plasmodium falciparum, probably by targeting stearoyl-CoA de-
saturase (SCD) [6]. We investigated the anti-parasitic activity 
of sterculic acid and methyl esters against T. gondii in vitro. 
Herein, we show that sterculic acid and its analogue methyl 
esters also inhibit the growth of T. gondii tachyzoites in vitro.
MATERIALS AND METHODS
Candidate compounds
Sterculic acid is a cyclopropene fatty acid. The analogues 
used in our experiments were methyl esters of cyclopropene 
fatty acids that had similar structures to sterculic acid (Fig. 1). 
INT15 is the corresponding methyl ester of sterculic acid while 
INT13 and INT14 has 1 less or 1 more carbon atom than 
INT15 in the chains, respectively. INT21 is composed of the 
backbone of INT15 and a methoxyl. The compounds were 
prepared as previously described [6-8]. DMSO was used to dis-
solve these compounds at 1 M as stock solutions.
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Abstract: Toxoplasmosis is a serious disease caused by Toxoplasma gondii, one of the most widespread parasites in the 
world. Lipid metabolism is important in the intracellular stage of T. gondii. Stearoyl-CoA desaturase (SCD), a key enzyme 
for the synthesis of unsaturated fatty acid is predicted to exist in T. gondii. Sterculic acid has been shown to specifically 
inhibit SCD activity. Here, we examined whether sterculic acid and its methyl ester analogues exhibit anti-T. gondii effects 
in vitro. T. gondii-infected Vero cells were disintegrated at 36 hr because of the propagation and egress of intracellular 
tachyzoites. All test compounds inhibited tachyzoite propagation and egress, reducing the number of ruptured Vero cells 
by the parasites. Sterculic acid and the methyl esters also inhibited replication of intracellular tachyzoites in HFF cells. 
Among the test compounds, sterculic acid showed the most potent activity against T. gondii, with an EC50 value of 36.2 
μM, compared with EC50 values of 248-428 μM for the methyl esters. Our study demonstrated that sterculic acid and its 
analogues are effective in inhibition of T. gondii growth in vitro, suggesting that these compounds or analogues targeting 
SCD could be effective agents for the treatment of toxoplasmosis.
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Host cells and T. gondii strain
Vero cells and human foreskin fibroblasts (HFF) were used 
to culture T. gondii. Vero cells replicate rapidly and undergo 
many cycles of division without becoming senescent, while 
the strong contact inhibition and slow growth of HFF make 
the cells of choice for monitoring parasite development under 
a microscope [9]. The cells were maintained in RPMI 1640 
medium (Vero cells) or DMEM (HFF) supplemented with 
10% FBS and penicillin (100 units/ml) and streptomycin (100 
μg/ml), and cultured at 37˚C in a humidified 5% CO2 incuba-
tor. Tachyzoites of the RH strain of T. gondii were maintained 
in Vero cells. The medium was changed to RPMI 1640 with 1% 
FBS to avoid overgrowing after the cells were inoculated with T. 
gondii. Tachyzoites were harvested and passed through a 5 μm 
filter when most of the parasites were still intracellular, and 
then the parasites were counted in a hemocytometer.
Tachyzoite release assay
Tachyzoite release from host cells in the presence of test 
compounds was observed as previously described with minor 
modifications [4]. Vero cells were cultured in 12-well plates 
until confluency, and then infected with 5×104 tachyzoites/
well. After incubation for 6 hr, extracellular tachyzoites were 
removed by washing with PBS. The cells were further cultured 
in DMEM with 2% FBS. To study the effect of the test com-
pounds on intracellular T. gondii, 1 mM (final concentration) 
of each compound or 0.1% DMSO as a negative control was 
added to the culture. The culture was observed for host cell 
rupture and tachyzoites release under an inverted microscope 
(Olympus IX71, Tokyo, Japan) and images were captured 
(Olympus DP70 camera) at 0, 12, 24, and 36 hr after the addi-
tion of the test compounds.
Tachyzoite proliferation assay
The effect of the test compounds on tachyzoite proliferation 
was studied using HFF. Freshly released tachyzoites (1×104 
tachyzoites/well) were inoculated in confluent HFF on 12-well 
plates for 30 min to allow cell invasion, followed by extensive 
washing and further incubation in DMEM with 2% FBS and 
0.1 mM sterculic acid or 1 mM methyl esters for 18 hr. Subse-
quently, the cells were fixed with 4% paraformaldehyde and 
permeabilized with 0.25% Triton X-100. The intracelullar para-
sites were incubated with anti-T. gondii rabbit sera (1:50) and 
then FITC-conjugated goat anti-rabbit IgG (1:50, Proteintech 
Group Inc., Chicago, Illinois, USA) for 1 hr at 37˚C for each 
antibody incubation step. Tachyzoites labelled with green fluo-
rescence were observed under an inverted microscope (Olym-
pus), and intracellular parasites at different proliferation stages 
(i.e. 1, 2, 4, or 8 tachyzoites) were counted from 100 parasi-
tophorous vacuoles in 3 separate wells per experiment.
Fig. 1. Molecular structures of test compounds. Sterculic acid was coded as INT16. The methyl esters INT13, INT14, and INT15 are dif-
ferent in the length of carbon chain. INT21 has the same length of carbon chain with sterculic acid but contains a methoxy moiety.
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MTS assay
This experiment was performed as previously described with 
minor modifications [4]. Vero cells of exponential growth 
stage were digested and cultured in 96-well plates at 6×103 
cells/well. The adherent cells were infected with T. gondii 
tachyzoites resuspended in RPMI 1640 containing 10% FBS 
(3×104 tachyzoites in 100 μl medium per well). The infected 
cells were washed 6 hr after inoculation, and RPMI 1640 me-
dium without FBS was added. After 18 hr, the medium in each 
well was changed into RPMI 1640 supplemented with 2% FBS 
along with different concentrations of sterculic acid or the 
methyl esters (final concentrations 15.6-1,000 μM). After treat-
ment for 24 hr, anti-T. gondii activity and host cell cytotoxicity 
of the test compounds were evaluated by the 3-(4,5-dimethyl-
thiazolzyl) -5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl) 
-2H-tetrazoliuzolium, inner salt (MTS) assay using the CellTi-
ter 96® AQueous One Solution Cell Proliferation Assay kit 
(Promega Biotech, Beijing, China) according to the manufac-
turer’s instruction. The OD value of each well was assayed at 
the wavelength of 450 nm on a microplate reader (Model 680, 
Bio-Rad, Richmond, California, USA). Cell viability was ex-
pressed as percentage of the control value. The 50% cytotoxici-
ty concentration (CC50) was expressed as the concentration re-
ducing Vero cell growth by 50%, and the 50% effective con-
centration (EC50) was the concentration inhibiting T. gondii-in-
duced cytopathic effect by 50%. Anti-T. gondii activity was ex-
pressed as the selectivity index calculated from the CC50 and 
EC50 values (CC50/EC50).
Statistical analysis
All experiments and measurements were performed in trip-
licate. The number of extracellular tachyzoites was compared 
using the Student’s t-test. The proliferation results were statisti-
cally analyzed using the chi-square test (PASW Statistics 18). 
EC50 and CC50 were calculated in GraphPad Prism 5 using 
non-linear regression.
RESULTS
Inhibitory activity against tachyzoite egress from host cells
Normal growth and proliferation of intraceullar tachyzoites 
result in host cell rupture and thus release of tachyzoites from 
the host cell. Prevention of tachyzoite egress from Vero cells 
was used as a marker for antiparasitic activity of the test com-
pounds. The high concentration of sterculic acid (1 mM) 
caused cell death within 12 hr (data not shown), while methyl 
ester analogues were not cytotoxic at 1 mM. Thus, concentra-
tions of 0.1 mM sterculic acid and 1 mM methyl esters were 
tested for antiparasitic activity in the Vero cell assay. Vero cells 
were unaffected at 12 hr and were of the same appearance in 
the treated and control groups. In the control group, tachyzo-
ites started to egress at 24 hr, and by 36 hr most of the tachyzo-
ites were released from the host cells with only a small num-
ber of intact cells remaining. Most host cells of all the treated 
groups remained intact at 36 hr (Fig. 2A-E), with a smaller 
number of tachyzoites released (Fig. 2G). The lowest number 
of extracellular tachyzoites was seen in the INT21-treated 
group, and the intracellular tachyzoites seemed to cease devel-
oping at 36 hr.
Inhibitory activity against tachyzoite proliferation
The decreased tachyzoite egress indicated that the test com-
pounds inhibited the growth of T. gondii tachyzoites. We then 
examined the anti-proliferation activity of the test compounds 
using the indirect fluorescent antibody assay. The number of 
parasitophorous vacuoles containing 1-8 intracellular tachyzo-
ites was counted after incubation in HFF for 18 hr. All test 
compounds inhibited tachyzoite proliferation. Significantly 
more parasitophorous vacuoles of all treated groups remained 
in the 1 or 2 tachyzoites per vacuole stage than the DMSO 
control (Fig. 3). Of the test compounds, INT21 was most effec-
tive, with over 90% parasitophorous vacuoles arresting at 2 or 
4 tachyzoites stage and only 3% grown into 8 tachyzoites. In 
other treated groups, about 30% of parasitophorous vacuoles 
contained 8 tachyzoites. In comparison, approximately 50% 
parasites developed to 4 tachyzoites and 40% to 8 per vacuole 
in the DMSO culture. 
Anti-T. gondii activity by MTS assay
Anti-T. gondii activity was also tested using the MTS assay. 
Vero cells grew normally in culture medium with methyl esters 
(INT13, INT14, and INT15) no matter whether the test con-
centration was low or high. INT21 seemed to promote the cell 
growth, especially in the low concentration. In contrast, stercu-
lic acid was cytotoxic to Vero cells (Fig. 4A), with a mean CC50 
of 215 μM. The viability of Vero cells infected with T. gondii 
was increased with increasing compound concentrations, indi-
cating anti-T. gondii activity of the test compounds (Fig. 4B). 
Sterculic acid had the lowest EC50 value (36.2 μM). The mean 
EC50 values for the methyl esters ranged from 248.0 μM 
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(INT21) to 428.4 μM (INT14). All the test compounds have a 
selectivity index of >2 (Table 1). The antiparasitic activity in 
MTS assay was consistent with the release assay and prolifera-
tion assay results, with INT21 being the most effective moiety 
of the methyl esters.
DISCUSSION
Our study showed that sterculic acid and its analogues all 
exhibited anti-T. gondii activities in vitro in 3 different assays – 
egress, proliferation, and MTS. Among the compounds exam-
ined, sterculic acid exhibited the lowest EC50 value against T. 
gondii by the MTS assay while it was also most toxic to Vero 
cells, hindering us from testing its effect in the proliferation as-
say with a higher concentration. The effect of sterculic acid on 
Vero cells or HFFs has not been reported previously. Our re-
sults showed that sterculic acid is cytotoxic at a high concentra-































Fig. 2. Sterculic acid and methyl esters inhibited the egress of tachyzoites from Vero cells. Representative pictures were presented to 
show that most of host cells remained intact after incubation with INT13 (A), INT14 (B), INT15 (C), INT16 (D), or INT21 (E) for 36 hr, with 
a small number of released tachyzoites, compared with numerous tachyzoites and a smaller number of intact host cells in the negative 
control group (F). Scale bar=100 μM. Extracellular tachyzoites are marked in red circles. (G) The number of released tachyzoites in the 
culture incubated with the test compounds was decreased relative to the DMSO control. Extracellular tachyzoites were counted in 6 
random fields under the microscope per group. Data are presented as mean±SD. **P<0.01.























Fig. 3. Sterculic acid and all methyl ester analogues inhibit tachyzoite proliferation. Freshly released parasites were used to infect HFF 
cell monolayers. (A) Invaded parasites were allowed to replicate for 18 hr in the culture medium containing the test compounds, and the 
number of vacuoles containing 1, 2, 4, or 8 parasites was counted under a fluorescence microscope after anti-T. gondii staining. (B) 
Representative fluorescent microscopic images were presented to show that many vacuoles contained 8 tachyzoites in DMSO control 
groups, (C) while 4 or 2 tachyzoites were often observed in a vacuole in INT21-treated groups after culture for 18 hr. The magnified im-
ages of the areas marked with white boxes in (B) and (C) were presented at the bottom in order. Data are presented as mean±SD from 
3 independent experiments each in triplicate. **P<0.01.
Fig. 4. Relative cell viability was calculated from the MTS assay. The cell viability of 0.1% DMSO was regarded as 100%. (A) Sterculic 
acid was cytotoxic to Vero cells at high concentrations while the methyl esters displayed no cytotoxicity. (B) All test compounds inhibited 




























































Table 1. In vitro anti-T. gondii activity of sterculic acid and its methyl ester analogues    
Compound code ECa 50 (μM) CC
b 50 (μM) SI
c
Sterculic acid (INT16) 36.2±5.1 215.2±15.8 5.9
INT13 356.9±14.1 >1,000 >2.8
INT14 428.4±15.7 >1,000 >2.3
INT15 306.4±18.8 >1,000 >3.3
INT21 248.0±17.9 >1,000 >4.0
Results are presented as mean±SD from 3 independent experiments with triplicate wells in each experiment.    
aEC50, half maximal effective concentration. Concentration required to inhibit T. gondii-induced cytopathic effect by 50%.    
bCC50, half maximal cytotoxic concentration. Concentration required to reduce Vero cell growth by 50%.    
cSelectivity index=CC50/EC50    
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entiated adipocyte cultures was decreased at higher levels of 
sterculic acid (100 μM or 200 μM) [10]. In contrast, the methyl 
esters did not exhibited negative effects on Vero cells and even 
increased the cell viability in low concentrations. Increased cell 
proliferation under methyl sterculate treatment was also ob-
served in early reports, and methyl ester of sterculic acid has 
been identified as one of the mitogenic principles [11,12]. 
INT21, the only methoxy analogue, was found to have little 
cytotoxicity and the most active in the inhibition of T. gondii 
growth among the methyl esters, which consisted with a previ-
ous report that the compound was the most active against P. 
falciparum among 7 methyl esters tested [6].
Sterculic acid directly inhibits stearoyl-coenzyme A desatu-
rase (SCD) activity without affecting the processes required for 
adipocyte differentiation, scd gene expression or SCD protein 
translation in 3T3-L1 adipocytes [13]. Sterculic acid methyl es-
ter also inhibits Δ9-desaturase of the bacteria Rhodococcus opa-
cus, leading to an almost complete suppression of growth at 
0.25 mM and even cell lysis at 0.75 mM [14]. Methyl esters of 
sterculic acid have also been shown to inhibit SCD of P. falci-
parum and exhibited antimalarial activities in vitro [6]. By se-
quence alignment with P. falciparum SCD in the ToxoDB data-
base, a putative TgSCD (TGGT1_238950) was predicted to ex-
ist in T. gondii, retaining classic Δ9-desaturase amino acid se-
quences, such as 3 Histidine-Boxes and 8 conserved His resi-
dues. Neither the transcription nor the translation of T. gondii 
SCD was affected in the presence of the test compounds in our 
research, determined by qPCR and western blot (data not 
shown). We implied that sterculic acid and its analogues 
might only inhibit the SCD activity in T. gondii. 
SCD is the endoplasmic reticulum-resident enzyme that cat-
alyzes the introduction of the first double bond in the cis-Δ9 
position of several saturated fatty acyl-CoAs, principally pal-
mitic acid (C16:0) and stearic acid (C18:0), to render palmi-
toleic acid (C16:1) and oleic acid (C18:1). The presence of 
SCD has been described in a wide variety of organisms [15]. 
SCD1, an isoform of SCD in mammalian organisms, apart 
from its role in monounsaturated fatty acids synthesis, has 
been recently revealed a novel function in the modulation of 
metabolic and signaling processes related to cell proliferation, 
survival, and malignant transformation to cancer [16]. In api-
complexan parasites, SCD has not been deeply studied but 
only identified in P. falciparum. It converted C18:0 to C18:1 
oleic acid and was important for the blood-stage survival [6]. 
However, C18:1 in T. gondii was presumably synthesized from 
the elongation of C16:1 palmitoleic acid by ELO-A (1 of 3 
elongases in the fatty acid elongation system) [17]. Besides de 
novo synthesis of the fatty acids, T. gondii can also salvage lip-
ids from the host cells and the environment [18,19]. It is pos-
sible that T. gondii desaturates salvaged C18:0 to C18:1 by 
SCD. Moreover, SCD can also catalyze the synthesis of C16:1 
using C16:0 as the substrate [20], suggesting that the synthesis 
of C16:1 palmitoleic acid may be mediated by SCD in T. gon-
dii. Therefore, TgSCD might be an essential enzyme in the mo-
no-unsaturated fatty acid synthesis in this parasite. We inferred 
that the anti-T. gondii activity of sterculic acid and its analogues 
is most likely mediated by inhibiting TgSCD.
In conclusion, sterculic acid and its analogues inhibited T. 
gondii growth in vitro, most likely by targeting the synthesis of 
unsaturated fatty acid, which is essential for the development 
and proliferation of T. gondii. In vivo anti-T. gondii effects of 
sterculic acid analogues and other Δ9-desaturase inhibitors 
warrant further research. The function of TgSCD also requires 
further investigation.
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